Severe acute hepatitis associated with morphazinamide therapy.
Zavaglia
C
C
Mondazzi
L
L
Fesce
E
E
Iamoni
G
G
Lanzani
F
F
Ideo
G
G
D000208:Acute Disease; D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D007565:Jaundice / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis; D008111:Liver Function Tests; D011719:Pyrazines / Q000009:adverse effects*
D000995:Antitubercular Agents; D015415:Biomarkers; D011719:Pyrazines; C038993:morphazinamide